{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:34:10Z","timestamp":1773671650914,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.7759\/cureus.105311","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:24:51Z","timestamp":1773667491000},"source":"Crossref","is-referenced-by-count":0,"title":["Re-evaluating Cardiovascular Risk: A Narrative Review Challenging the Cholesterol Hypothesis and Identifying Modern Dietary Drivers"],"prefix":"10.7759","author":[{"given":"Mitchell B","family":"Liester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna D","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301226","article-title":"The decline and rise of coronary heart disease: understanding public health catastrophism","volume":"103","author":"Jones DS","year":"2013","unstructured":"Jones DS, Greene JA. The decline and rise of coronary heart disease: understanding public health catastrophism. Am J Public Health. 2013, 103:1207-18. 10.2105\/AJPH.2013.301226","journal-title":"Am J Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2008.080114","article-title":"An unsuitable and degraded diet? Part three: Victorian consumption patterns and their health benefits","volume":"101","author":"Rowbotham J","year":"2008","unstructured":"Rowbotham J, Clayton P. An unsuitable and degraded diet? Part three: Victorian consumption patterns and their health benefits. J R Soc Med. 2008, 101:454-62. 10.1258\/jrsm.2008.080114","journal-title":"J R Soc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2016.08.004","article-title":"Global shifts in cardiovascular disease, the epidemiologic transition, and other contributing factors: toward a new practice of global health cardiology","volume":"35","author":"Mendoza W","year":"2017","unstructured":"Mendoza W, Miranda JJ. Global shifts in cardiovascular disease, the epidemiologic transition, and other contributing factors: toward a new practice of global health cardiology. Cardiol Clin. 2017, 35:1-12. 10.1016\/j.ccl.2016.08.004","journal-title":"Cardiol Clin"},{"key":"ref4","article-title":"NOVA. The star shines bright","volume":"7","author":"Monteiro C","year":"2016","unstructured":"Monteiro C, Cannon G, Levy R, et al.. NOVA. The star shines bright. World Nutr. 2016, 7:1-3.","journal-title":"World Nutr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2011.00982.x","article-title":"Time use and physical activity: a shift away from movement across the globe","volume":"13","author":"Ng SW","year":"2012","unstructured":"Ng SW, Popkin BM. Time use and physical activity: a shift away from movement across the globe. Obes Rev. 2012, 13:659-80. 10.1111\/j.1467-789X.2011.00982.x","journal-title":"Obes Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001119","article-title":"Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence","volume":"128","author":"Ros E","year":"2013","unstructured":"Ros E, Hu FB. Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence. Circulation. 2013, 128:553-65. 10.1161\/CIRCULATIONAHA.112.001119","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/193229680700100316","article-title":"Replacements for trans fats\u2014will there be an oil shortage?","volume":"1","author":"Klonoff DC","year":"2007","unstructured":"Klonoff DC. Replacements for trans fats\u2014will there be an oil shortage?. J Diabetes Sci Technol. 2007, 1:415-22. 10.1177\/193229680700100316","journal-title":"J Diabetes Sci Technol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602976","article-title":"Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils","volume":"63 Suppl 2","author":"Mozaffarian D","year":"2009","unstructured":"Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr. 2009, 63 Suppl 2:S22-33. 10.1038\/sj.ejcn.1602976","journal-title":"Eur J Clin Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2010.526872","article-title":"Trans-fats and coronary heart disease","volume":"50","author":"Kris-Etherton PM","year":"2010","unstructured":"Kris-Etherton PM. Trans-fats and coronary heart disease. Crit Rev Food Sci Nutr. 2010, 50:29-30. 10.1080\/10408398.2010.526872","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.79","article-title":"Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes","volume":"5","author":"Micha R","year":"2009","unstructured":"Micha R, Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol. 2009, 5:335-44. 10.1038\/nrendo.2009.79","journal-title":"Nat Rev Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2011.34","article-title":"Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies","volume":"65","author":"Bendsen NT","year":"2011","unstructured":"Bendsen NT, Christensen R, Bartels EM, Astrup A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr. 2011, 65:773-83. 10.1038\/ejcn.2011.34","journal-title":"Eur J Clin Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2009.12.024","article-title":"Trans fats in America: a review of their use, consumption, health implications, and regulation","volume":"110","author":"Remig V","year":"2010","unstructured":"Remig V, Franklin B, Margolis S, Kostas G, Nece T, Street JC. Trans fats in America: a review of their use, consumption, health implications, and regulation. J Am Diet Assoc. 2010, 110:585-92. 10.1016\/j.jada.2009.12.024","journal-title":"J Am Diet Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.03.033","article-title":"Trans fatty acids and lipid profile: a serious risk factor to cardiovascular disease, cancer and diabetes","volume":"13","author":"Islam MA","year":"2019","unstructured":"Islam MA, Amin MN, Siddiqui SA, Hossain MP, Sultana F, Kabir MR. Trans fatty acids and lipid profile: a serious risk factor to cardiovascular disease, cancer and diabetes. Diabetes Metab Syndr. 2019, 13:1643-7. 10.1016\/j.dsx.2019.03.033","journal-title":"Diabetes Metab Syndr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.679985","article-title":"A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease","volume":"115","author":"Sun Q","year":"2007","unstructured":"Sun Q, Ma J, Campos H, et al.. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007, 115:1858-65. 10.1161\/CIRCULATIONAHA.106.679985","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272744","article-title":"Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: socioeconomic analysis using the IMPACTsec model","volume":"17","author":"Bjoernsbo KS","year":"2022","unstructured":"Bjoernsbo KS, Joensen AM, Joergensen T, et al.. Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: socioeconomic analysis using the IMPACTsec model. PLoS One. 2022, 17:e0272744. 10.1371\/journal.pone.0272744","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R043414","article-title":"In celebration of the 100th anniversary of the lipid hypothesis of atherosclerosis","volume":"54","author":"Steinberg D","year":"2013","unstructured":"Steinberg D. In celebration of the 100th anniversary of the lipid hypothesis of atherosclerosis. J Lipid Res. 2013, 54:2946-9. 10.1194\/jlr.R043414","journal-title":"J Lipid Res"},{"key":"ref17","article-title":"Cornelis de Langen: Diet-Heart Theory, 1916","author":"Blackburn H","year":"2014","unstructured":"Blackburn H. Cornelis de Langen: Diet-Heart Theory, 1916. University of Minnesota, School of Public Health, Minneapolis, MN; 2014."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000898","article-title":"Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis","volume":"5","author":"DiNicolantonio JJ","year":"2018","unstructured":"DiNicolantonio JJ, O'Keefe JH. Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis. Open Heart. 2018, 5:e000898. 10.1136\/openhrt-2018-000898","journal-title":"Open Heart"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114480","article-title":"The diet and 15-year death rate in the Seven Countries Study","volume":"124","author":"Keys A","year":"1986","unstructured":"Keys A, Menotti A, Karvonen MJ, et al.. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol. 1986, 124:903-15. 10.1093\/oxfordjournals.aje.a114480","journal-title":"Am J Epidemiol"},{"key":"ref20","article-title":"Food Politics: How the Food Industry Influences Nutrition and Health","author":"Nestle M","year":"2013","unstructured":"Nestle M. Food Politics: How the Food Industry Influences Nutrition and Health. University of California Press, Berkeley (CA); 2013."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12040141","article-title":"Ancel Keys, the Mediterranean diet, and the Seven Countries Study: a review","volume":"12","author":"Menotti A","year":"2025","unstructured":"Menotti A, Puddu PE. Ancel Keys, the Mediterranean diet, and the Seven Countries Study: a review. J Cardiovasc Dev Dis. 2025, 12:10.3390\/jcdd12040141","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000791","article-title":"A short history of saturated fat: the making and unmaking of a scientific consensus","volume":"30","author":"Teicholz N","year":"2023","unstructured":"Teicholz N. A short history of saturated fat: the making and unmaking of a scientific consensus. Curr Opin Endocrinol Diabetes Obes. 2023, 30:65-71. 10.1097\/MED.0000000000000791","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.5394","article-title":"Sugar industry and coronary heart disease research: a historical analysis of internal industry documents","volume":"176","author":"Kearns CE","year":"2016","unstructured":"Kearns CE, Schmidt LA, Glantz SA. Sugar industry and coronary heart disease research: a historical analysis of internal industry documents. JAMA Intern Med. 2016, 176:1680-5. 10.1001\/jamainternmed.2016.5394","journal-title":"JAMA Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2020","article-title":"The scientific basis of guideline recommendations on sugar intake: a systematic review","volume":"166","author":"Erickson J","year":"2017","unstructured":"Erickson J, Sadeghirad B, Lytvyn L, Slavin J, Johnston BC. The scientific basis of guideline recommendations on sugar intake: a systematic review. Ann Intern Med. 2017, 166:257-67. 10.7326\/M16-2020","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.100305","article-title":"Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis","volume":"102","author":"Berger S","year":"2015","unstructured":"Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2015, 102:276-94. 10.3945\/ajcn.114.100305","journal-title":"Am J Clin Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114545","article-title":"Characteristics of human hypo- and hyperresponders to dietary cholesterol","volume":"125","author":"Katan MB","year":"1987","unstructured":"Katan MB, Beynen AC. Characteristics of human hypo- and hyperresponders to dietary cholesterol. Am J Epidemiol. 1987, 125:387-99. 10.1093\/oxfordjournals.aje.a114545","journal-title":"Am J Epidemiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2392","article-title":"History of modern nutrition science\u2014implications for current research, dietary guidelines, and food policy","volume":"361","author":"Mozaffarian D","year":"2018","unstructured":"Mozaffarian D, Rosenberg I, Uauy R. History of modern nutrition science\u2014implications for current research, dietary guidelines, and food policy. BMJ. 2018, 361:k2392. 10.1136\/bmj.k2392","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1116","article-title":"Dietary guidelines in the 21st century\u2014a time for food","volume":"304","author":"Mozaffarian D","year":"2010","unstructured":"Mozaffarian D, Ludwig DS. Dietary guidelines in the 21st century\u2014a time for food. JAMA. 2010, 304:681-2. 10.1001\/jama.2010.1116","journal-title":"JAMA"},{"key":"ref29","unstructured":"Dietary guidelines for Americans 2015-2020. (2015). Accessed. February 13, 2026: https:\/\/www.google.com\/books\/edition\/Dietary_Guidelines_for_Americans_2015_20\/iYtfDQAAQBAJ?hl=en&gbpv=1&dq=U.S.+Depar...."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.27725","article-title":"Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease","volume":"91","author":"Siri-Tarino PW","year":"2010","unstructured":"Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010, 91:535-46. 10.3945\/ajcn.2009.27725","journal-title":"Am J Clin Nutr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuz091","article-title":"Dietary saturated fat and heart disease: a narrative review","volume":"78","author":"Heileson JL","year":"2020","unstructured":"Heileson JL. Dietary saturated fat and heart disease: a narrative review. Nutr Rev. 2020, 78:474-85. 10.1093\/nutrit\/nuz091","journal-title":"Nutr Rev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2024-0324","article-title":"Saturated fat restriction for cardiovascular disease prevention: a systematic review and meta\u2011analysis of randomized controlled trials","volume":"8","author":"Yamada S","year":"2025","unstructured":"Yamada S, Shirai T, Inaba S, Inoue G, Torigoe M, Fukuyama N. Saturated fat restriction for cardiovascular disease prevention: a systematic review and meta\u2011analysis of randomized controlled trials. JMA J. 2025, 8:395-407. 10.31662\/jmaj.2024-0324","journal-title":"JMA J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.077","article-title":"Saturated fats and health: a reassessment and proposal for food\u2011based recommendations: JACC state-of-the-art review","volume":"76","author":"Astrup A","year":"2020","unstructured":"Astrup A, Magkos F, Bier DM, et al.. Saturated fats and health: a reassessment and proposal for food\u2011based recommendations: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:844-57. 10.1016\/j.jacc.2020.05.077","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.22454\/FamMed.2025.991804","article-title":"Dark calories: how vegetable oils destroy our health and how we can get it back","volume":"57","author":"Scherger JE","year":"2025","unstructured":"Scherger JE. Dark calories: how vegetable oils destroy our health and how we can get it back. Fam Med. 2025, 57:314-5. 10.22454\/FamMed.2025.991804","journal-title":"Fam Med"},{"key":"ref35","article-title":"Consumption of repeatedly heated soy oil increases the serum parameters related to atherosclerosis in ovariectomized rats","volume":"215","author":"Adam SK","year":"2008","unstructured":"Adam SK, Das S, Soelaiman IN, Umar NA, Jaarin K. Consumption of repeatedly heated soy oil increases the serum parameters related to atherosclerosis in ovariectomized rats. Tohoku J Exp Med. 2008, 215:219-26.","journal-title":"Tohoku J Exp Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7080102","article-title":"Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders","volume":"7","author":"Barrera G","year":"2018","unstructured":"Barrera G, Pizzimenti S, Daga M, et al.. Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants (Basel). 2018, 7:10.3390\/antiox7080102","journal-title":"Antioxidants (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1035-2","article-title":"Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies","volume":"18","author":"Zhu Y","year":"2019","unstructured":"Zhu Y, Bo Y, Liu Y. Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies. Lipids Health Dis. 2019, 18:91. 10.1186\/s12944-019-1035-2","journal-title":"Lipids Health Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.4.498","article-title":"Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective","volume":"42","author":"Jialal I","year":"1996","unstructured":"Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem. 1996, 42:498-506. 10.1093\/clinchem\/42.4.498","journal-title":"Clin Chem"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra054035","article-title":"Trans fatty acids and cardiovascular disease","volume":"354","author":"Mozaffarian D","year":"2006","unstructured":"Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006, 354:1601-13. 10.1056\/NEJMra054035","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000053730.47739.3c","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker PM","year":"2003","unstructured":"Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003, 107:363-9. 10.1161\/01.cir.0000053730.47739.3c","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge S","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, et al.. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010, 375:132-40. 10.1016\/S0140-6736(09)61717-7","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker PM","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al.. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008, 359:2195-207. 10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson TA","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al.. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107:499-511. 10.1161\/01.cir.0000052939.59093.45","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.068885","article-title":"Apolipoprotein B: bridging the gap between evidence and clinical practice","volume":"150","author":"De Oliveira-Gomes D","year":"2024","unstructured":"De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM. Apolipoprotein B: bridging the gap between evidence and clinical practice. Circulation. 2024, 150:62-79. 10.1161\/CIRCULATIONAHA.124.068885","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low\u2011density lipoprotein cholesterol and non\u2011high\u2011density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic T","year":"2022","unstructured":"Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD. Physiological bases for the superiority of apolipoprotein B over low\u2011density lipoprotein cholesterol and non\u2011high\u2011density lipoprotein cholesterol as a marker of cardiovascular risk. J Am Heart Assoc. 2022, 11:e025858. 10.1161\/JAHA.122.025858","journal-title":"J Am Heart Assoc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0692","article-title":"Discordance between apolipoprotein B and low-density lipoprotein cholesterol and progression of coronary artery calcification in middle age","volume":"85","author":"Kim CW","year":"2021","unstructured":"Kim CW, Hong S, Chang Y, Lee JA, Shin H, Ryu S. Discordance between apolipoprotein B and low-density lipoprotein cholesterol and progression of coronary artery calcification in middle age. Circ J. 2021, 85:900-7. 10.1253\/circj.CJ-20-0692","journal-title":"Circ J"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard BG","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, et al.. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010, 31:2844-53. 10.1093\/eurheartj\/ehq386","journal-title":"Eur Heart J"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas S","year":"2017","unstructured":"Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017, 69:692-711. 10.1016\/j.jacc.2016.11.042","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou S","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL, et al.. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009, 302:412-23. 10.1001\/jama.2009.1063","journal-title":"JAMA"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup PR","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009, 301:2331-9. 10.1001\/jama.2009.801","journal-title":"JAMA"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020, 41:111-188. 10.1016\/j.atherosclerosis.2019.08.014","journal-title":"Eur Heart J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI Working Group recommendations to reduce lipoprotein(a)\u2011mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas S","year":"2018","unstructured":"Tsimikas S, Fazio S, Ferdinand KC, et al.. NHLBI Working Group recommendations to reduce lipoprotein(a)\u2011mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol. 2018, 71:177-92. 10.1016\/j.jacc.2017.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/0884533609335376","article-title":"Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease","volume":"24","author":"Bowden RG","year":"2009","unstructured":"Bowden RG, Wilson RL, Deike E, Gentile M. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract. 2009, 24:508-12. 10.1177\/0884533609335376","journal-title":"Nutr Clin Pract"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora S","year":"2014","unstructured":"Mora S, Buring JE, Ridker PM. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014, 129:553-61. 10.1161\/CIRCULATIONAHA.113.005873","journal-title":"Circulation"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos JD","year":"2011","unstructured":"Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011, 5:105-13. 10.1016\/j.jacl.2011.02.001","journal-title":"J Clin Lipidol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora S","year":"2009","unstructured":"Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009, 119:931-9. 10.1161\/CIRCULATIONAHA.108.816181","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13693","article-title":"Small dense LDL: an underestimated driver of atherosclerosis (review)","volume":"32","author":"Bekbossynova M","year":"2025","unstructured":"Bekbossynova M, Saliev T, Ivanova-Razumova T, et al.. Small dense LDL: an underestimated driver of atherosclerosis (review). Mol Med Rep. 2025, 32:10.3892\/mmr.2025.13693","journal-title":"Mol Med Rep"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.1097\/00041433-199606000-00010","article-title":"Small, dense low density lipoproteins, the insulin resistance syndrome and non-insulin\u2011dependent diabetes","volume":"7","author":"Austin MA","year":"1996","unstructured":"Austin MA, Edwards KL. Small, dense low density lipoproteins, the insulin resistance syndrome and non-insulin\u2011dependent diabetes. Curr Opin Lipidol. 1996, 7:167-71.","journal-title":"Curr Opin Lipidol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00215-4","article-title":"Low\u2011density lipoprotein particle size and risk factors of insulin resistance syndrome","volume":"148","author":"Friedlander Y","year":"2000","unstructured":"Friedlander Y, Kidron M, Caslake M, Lamb T, McConnell M, Bar\u2011On H. Low\u2011density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis. 2000, 148:141-9. 10.1016\/S0021-9150(99)00215-4","journal-title":"Atherosclerosis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin T","year":"2003","unstructured":"McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003, 139:802-9. 10.7326\/0003-4819-139-10-200311180-00007","journal-title":"Ann Intern Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic syndrome update","volume":"26","author":"Grundy SM","year":"2016","unstructured":"Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016, 26:364-73. 10.1016\/j.tcm.2015.10.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.07.008","article-title":"Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men","volume":"104","author":"Cordero A","year":"2009","unstructured":"Cordero A, Andr\u00e9s E, Ordo\u00f1ez B, et al.. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. Am J Cardiol. 2009, 104:1393-7. 10.1016\/j.amjcard.2009.07.008","journal-title":"Am J Cardiol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2008.09.003","article-title":"Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men","volume":"19","author":"Hadaegh F","year":"2009","unstructured":"Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009, 19:401-8. 10.1016\/j.numecd.2008.09.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12036","article-title":"Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria","volume":"273","author":"Salazar MR","year":"2013","unstructured":"Salazar MR, Carbajal HA, Espeche WG, et al.. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med. 2013, 273:595-601. 10.1111\/joim.12036","journal-title":"J Intern Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1395","article-title":"Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans","volume":"165","author":"Sumner AE","year":"2005","unstructured":"Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005, 165:1395-400. 10.1001\/archinte.165.12.1395","journal-title":"Arch Intern Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036819","article-title":"Dietary cholesterol and myocardial infarction in the Million Veteran Program","volume":"14","author":"Nguyen XT","year":"2025","unstructured":"Nguyen XT, Li Y, Nyaeme MS, et al.. Dietary cholesterol and myocardial infarction in the Million Veteran Program. J Am Heart Assoc. 2025, 14:e036819. 10.1161\/JAHA.124.036819","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468658-re-evaluating-cardiovascular-risk-a-narrative-review-challenging-the-cholesterol-hypothesis-and-identifying-modern-dietary-drivers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:24:54Z","timestamp":1773667494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468658-re-evaluating-cardiovascular-risk-a-narrative-review-challenging-the-cholesterol-hypothesis-and-identifying-modern-dietary-drivers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.105311","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}